PPMI focus on LRRK2 gene profiled in two South Florida newspapers

PPMI efforts to identify individuals with a mutation in their LRRK2 gene are heavily focused on the Ashkenazi Jewish population in South Florida.  Earlier this month, Florida newspaper Sun Sentinel reported on the prevalence of the LRRK2 genetic mutations in that population and the need for them to receive genetic testing and participate in the prodromal cohort of PPMI.  Dr. Stuart Isaacson, director of PPMI site Parkinson?s Disease and Movement Disorders Center of Boca Raton, was interviewed.

Here is an excerpt from the article:

“This is one of the most important studies going on right now in Parkinson’s disease,” Isaacson said. “Because while we have a lot of medicines to treat the symptoms, we are in desperate need of diagnosing the disease earlier so we can slow, arrest or reverse it. We need to identify the biomarkers in order to do that.”

South Florida has one of the world’s three largest concentrations of Ashkenazi Jews, a group that is more likely to carry the LRRK2 gene than the general population, Isaacson said.

PPMI?s focus on the LRRK2 gene in South Florida was also profiled in local paper The Jewish Journal